Report - Neoplasias Mieloproliferativas Crónicas · 2012. 6. 8. · Months Ruxolitinib N=107 Control Survival Probability N=310 0 p-value = 0.022 6 1218 24 3036 MDACC Mayo-Rochester* *Estimated

Please pass captcha verification before submit form